BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24687667)

  • 1. Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension.
    Souza R; Fernandes CJ; Hoeper MM
    Eur Respir J; 2014 Apr; 43(4):963-5. PubMed ID: 24687667
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension.
    Trip P; Girerd B; Bogaard HJ; de Man FS; Boonstra A; Garcia G; Humbert M; Montani D; Vonk-Noordegraaf A
    Eur Respir J; 2014 Apr; 43(4):1195-8. PubMed ID: 24036241
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatic mutations in pulmonary arterial hypertension: primary or secondary events?
    Austin ED; Hamid R; Ahmad F
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1094-6. PubMed ID: 21041561
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.
    Frydman N; Steffann J; Girerd B; Frydman R; Munnich A; Simonneau G; Humbert M
    Eur Respir J; 2012 Jun; 39(6):1534-5. PubMed ID: 22654007
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
    Roberts KE; Barst RJ; McElroy JJ; Widlitz A; Chada K; Knowles JA; Morse JH
    Chest; 2005 Dec; 128(6 Suppl):618S. PubMed ID: 16373874
    [No Abstract]   [Full Text] [Related]  

  • 6. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension.
    Hayes D; Ramanathan C; Kopp BT
    Pediatr Pulmonol; 2014 Jan; 49(1):E5-6. PubMed ID: 23139147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Kataoka M; Satoh T; Fukuda K
    Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
    [No Abstract]   [Full Text] [Related]  

  • 8. BMPR2 mutation and outcome in pulmonary arterial hypertension: clinical relevance to physicians and patients.
    Rubin LJ
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1300-1. PubMed ID: 18522952
    [No Abstract]   [Full Text] [Related]  

  • 9. Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    van der Bruggen CE; Happé CM; Goumans MJ; Bogaard HJ; Vonk Noordegraaf A; de Man FS
    Circulation; 2016 Aug; 134(9):e117-8. PubMed ID: 27572883
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.
    Hamid R; Loyd J
    Eur Respir J; 2012 Jun; 39(6):1292-3. PubMed ID: 22654004
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
    Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression.
    Liu D; Yan Y; Chen JW; Yuan P; Wang XJ; Jiang R; Wang L; Zhao QH; Wu WH; Simonneau G; Qu JM; Jing ZC
    Am J Respir Crit Care Med; 2017 Oct; 196(7):925-928. PubMed ID: 28170297
    [No Abstract]   [Full Text] [Related]  

  • 13. Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.
    Wang G; Knight L; Ji R; Lawrence P; Kanaan U; Li L; Das A; Cui B; Zou W; Penny DJ; Fan Y
    Int J Cardiol; 2014 Dec; 177(3):e167-9. PubMed ID: 25189502
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade.
    Isobe S; Kataoka M; Aimi Y; Gamou S; Satoh T; Fukuda K
    Am J Respir Crit Care Med; 2016 Jun; 193(11):1310-4. PubMed ID: 27248591
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity.
    Eyries M; Soubrier F
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1003-1004. PubMed ID: 27634583
    [No Abstract]   [Full Text] [Related]  

  • 16. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update in pulmonary arterial hypertension 2007.
    Humbert M
    Am J Respir Crit Care Med; 2008 Mar; 177(6):574-9. PubMed ID: 18316769
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.
    Machado RD
    Eur Respir J; 2012 Feb; 39(2):235-7. PubMed ID: 22298609
    [No Abstract]   [Full Text] [Related]  

  • 20. The genomic complexity underlying pulmonary arterial hypertension: from mendel to networks.
    Rajkumar R; Ahmad F
    Am J Respir Crit Care Med; 2014 May; 189(10):1152-4. PubMed ID: 24832737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.